Scholarlink

Background <p>As the Americas move towards malaria elimination, its circulation is increasingly concentrated in isolated communities with poor access to healthcare, and the silent human reservoir is a challenge (particularly for <i>Plasmodium vivax</i>). The deployment of tafenoquine for radical treatment is an important new asset. The CUREMA project evaluates a complex intervention aiming at malaria elimination in artisanal and small-scale gold mining (ASGM) communities of the Guiana Shield Region. A pre-intervention assessment was conducted to explore ASGM populations’ knowledge and perceptions of asymptomatic <i>Plasmodium</i> carriage and <i>P. vivax</i> malaria.</p> Methods <p>The target population was the ASGM community working across Suriname, French Guiana and Amapá (Brazil). Data was collected in 2022 in ASGM cross-border staging areas, during the CUREMA pre-intervention qualitative and quantitative (cross-sectional) surveys. This analysis explores knowledge, experiences and representations on asymptomatic plasmodial carriage, recurrences and <i>P. vivax</i> infections.</p> Results <p>The qualitative survey included 25 semi-structured interviews, 14 group interviews and 38 informal conversations. The quantitative survey included 539 participants, mostly men (73.5%), with a median age of 38&#xa0;years. Almost all the participants recognized mosquitoes as vectors of malaria, and a fraction recognized a microorganism as the causative agent of the disease.&#xa0;Awareness of asymptomatic forms of the disease (“<i>malária incubada”</i>) and of risk of recurrences was common, and they were generally considered to be the result of inadequate treatment. Most participants could identify different types of malaria, but knowledge about <i>P. vivax</i> characteristics and radical treatment was limited.</p> Conclusions <p>Understanding the interpretation of the disease by affected communities is essential to develop context-specific strategies and for enhancing acceptability and effectiveness of malaria elimination efforts.</p> <p><i>Trial registration</i> NCT05540470 on clinical trials</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Malária incubada: a mixed methods analysis on knowledge and experiences on Plasmodium vivax and asymptomatic malaria infections in a hard-to-reach and mobile population in the Amazon

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月3日

查看全文
  • Lorraine Plessis,
  • Irene Jimeno Maroto,
  • Yann Lambert,
  • Muriel Galindo,
  • Teddy Bardon,
  • Stephen Vreden,
  • Martha Suarez-Mutis,
  • Amanda Figueira,
  • Jane Miller Bordalo,
  • Maylis Douine,
  • Alice Sanna

摘要

Background

As the Americas move towards malaria elimination, its circulation is increasingly concentrated in isolated communities with poor access to healthcare, and the silent human reservoir is a challenge (particularly for Plasmodium vivax). The deployment of tafenoquine for radical treatment is an important new asset. The CUREMA project evaluates a complex intervention aiming at malaria elimination in artisanal and small-scale gold mining (ASGM) communities of the Guiana Shield Region. A pre-intervention assessment was conducted to explore ASGM populations’ knowledge and perceptions of asymptomatic Plasmodium carriage and P. vivax malaria.

Methods

The target population was the ASGM community working across Suriname, French Guiana and Amapá (Brazil). Data was collected in 2022 in ASGM cross-border staging areas, during the CUREMA pre-intervention qualitative and quantitative (cross-sectional) surveys. This analysis explores knowledge, experiences and representations on asymptomatic plasmodial carriage, recurrences and P. vivax infections.

Results

The qualitative survey included 25 semi-structured interviews, 14 group interviews and 38 informal conversations. The quantitative survey included 539 participants, mostly men (73.5%), with a median age of 38 years. Almost all the participants recognized mosquitoes as vectors of malaria, and a fraction recognized a microorganism as the causative agent of the disease. Awareness of asymptomatic forms of the disease (“malária incubada”) and of risk of recurrences was common, and they were generally considered to be the result of inadequate treatment. Most participants could identify different types of malaria, but knowledge about P. vivax characteristics and radical treatment was limited.

Conclusions

Understanding the interpretation of the disease by affected communities is essential to develop context-specific strategies and for enhancing acceptability and effectiveness of malaria elimination efforts.

Trial registration NCT05540470 on clinical trials